- Home
- PSQH vs ATRA Comparison
PSQH vs ATRA Comparison
Compare PSQH & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSQH | ATRA |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | United States |
| Employees | 85 | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | PSQH | ATRA |
|---|---|---|
| Price | $0.75 | $8.86 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 337.9K | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | $80.20 | N/A |
| Revenue Next Year | $34.74 | N/A |
| P/E Ratio | ★ N/A | $3.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.48 | $3.92 |
| 52 Week High | $2.84 | $19.15 |
Technical Indicators
Market Signals| Indicator | PSQH | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 54.10 | 69.47 |
| Support Level | $0.61 | $4.35 |
| Resistance Level | $0.82 | $13.14 |
| Average True Range (ATR) | 0.07 | 0.90 |
| MACD | 0.00 | 0.49 |
| Stochastic Oscillator | 43.35 | 54.85 |
Price Performance
Historical ComparisonAbout PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).